Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
RTI International
mi
from
Durham, NC
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Univeristy of Pennsylvania
mi
from
Philadelphia, PA
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Univeristy of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury
Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury
Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute
mi
from
Rockville, MD
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute
mi
from
Rockville, MD
Click here to add this to my saved trials
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Denver Health/University of Colorado Health Sciences Center
mi
from
Denver, CO
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Denver Health/University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Yale University Medical Center
mi
from
New Haven, CT
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Yale University Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Albert Einstein Medical College-Montefiore Medical Center
mi
from
Bronx, NY
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Albert Einstein Medical College-Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Moses Cone Health System
mi
from
Greensboro, NC
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Moses Cone Health System
mi
from
Greensboro, NC
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
The Ohio State Medical Center
mi
from
Columbus, OH
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
The Ohio State Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Baylor Health Care System
mi
from
Dallas, TX
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Baylor Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham, UABMC
mi
from
Birmingham, AL
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham, UABMC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
University Medical Center
mi
from
Tucson, AZ
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Desert Medical Imaging
mi
from
Indian Wells, CA
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Desert Medical Imaging
mi
from
Indian Wells, CA
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Children's Memorial Hospital
mi
from
Chicago, IL
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Precise Clinical Research Solutions
mi
from
Topeka, KA
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Precise Clinical Research Solutions
mi
from
Topeka, KA
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Louisville Hospital
mi
from
Louisville, KY
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Louisville Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Neurocare Center for Research
mi
from
Brookline, MA
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Neurocare Center for Research
mi
from
Brookline, MA
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
QUEST Research Institute
mi
from
Farmington Hills, MI
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Gruss Magnetic resonance Research Clinic
mi
from
New York, NY
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Gruss Magnetic resonance Research Clinic
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
WestImage - Division of Research
mi
from
Cincinnati, OH
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
WestImage - Division of Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials